IPS Research

Oklahoma City, Oklahoma 73106

0 studies enrolling now · 28 studies all time

What they study most

ADHD, Acute Pain, Adjunctive Treatment of Major Depressive Disorder, Alzheimer Disease, Asthma, Attention Deficit Disorder With Hyperactivity, Attention Deficit Hyperactivity Disorder, Attention Deficit/Hyperactivity Disorder, Attention-Deficit/Hyperactivity Disorder, Back Pain, Back Spasm Upper Back, Back Strain

Studies at this site

• Open-label Study to Evaluate Long-term Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule) — Running, not enrolling
• A Trial of Centanafadine Long-term Safety in Children and Adolescents With Attention-deficit/Hyperactivity Disorder. — Completed
• Zelquistinel in the Treatment of Major Depressive Disorder — Completed
• Long-term Safety Study of Adjunctive Troriluzole in Subjects With Obsessive Compulsive Disorder — Stopped early
• Phase 2a Study of Safety and Tolerability of SPN-810 in Children With ADHD and Persistent Serious Conduct Problems — Completed
• An Efficacy and Safety Study of ALZ-801 in APOE4/4 Early AD Subjects — Completed
• Identification of Patients With a High Probability of Meeting Eligibility Criteria for an Alzheimer's Disease Clinical Trial (APHELEIA) — Completed
• Software Treatment for Actively Reducing Severity of ADHD in Adolescents (STARS-ADHD-Adolescents) — Completed
• Software Treatment for Actively Reducing Severity of ADHD in Adults (STARS ADHD Adult) — Completed
• To Compare the Pharmacokinetics of Budesonide Delivered by BDA MDI to Budesonide Delivered by Pulmicort Respules in Children With Asthma Aged 4 to 8 Years. — Completed
• A Study of TD-9855 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) — Completed
• Efficacy, Safety, and Tolerability of Levomilnacipran ER in Pediatric Patients (7-17 Years) With Major Depressive Disorder — Completed
• Tolperisone in Acute Muscle Spasm of the Back — Completed
• Evaluation of SPN-812 (Viloxazine Extended-release Capsule) High Dose in Adolescents With ADHD — Completed
• Efficacy and Safety of SPD503 in Combination With Psychostimulants — Completed
• A Study Of The Efficacy And Safety Of CP-601,927 Augmentation Of Antidepressant Therapy In Major Depression — Stopped early
• Trial to Evaluate the Long-term Efficacy of Oral Aripiprazole in the Treatment of Pediatric Participants With Tourette's Disorder — Stopped early
• Open-label Long Term (52 Weeks) Safety and Tolerability of Agomelatine Sublingual Tablets in Major Depressive Disorder (MDD) — Stopped early
• Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder — Completed
• A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder — Completed
• Study to Evaluate the Efficacy and Safety of Adjunctive Pimavanserin in Major Depressive Disorder (CLARITY) — Completed
• A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01) — Completed
• Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Children (3 to < 9 Years) — Completed
• Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Non-Elderly and Elderly Adults — Completed
• A Study of the Treatment-Sparing Effects of AEROVANT™ AER 001 Inhalation Powder in Asthma Patients, AEROTRIAL — Completed
• Safety and Efficacy of Study Drug Versus Placebo for Negative Symptoms of Schizophrenia — Completed
• A Study for the Treatment of Mania Associated With Bipolar I Disorder in Children and Adolescents — Completed
• Depakote Monotherapy, Olanzapine Monotherapy, and Combination Therapy of Depakote Plus Olanzapine in Stable Subjects During the Maintenance Phase of Bipolar Illness — Stopped early